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ABSTRACT 
Anterior ischemic optic neuropathy (AION) is a relatively common cause of visual loss and 
results from hypoperfusion of the small arteries of the anterior portion of the optic nerve. 
AION is the leading cause of sudden optic nerve related vision loss with approximately 10 
cases per 100’000 in the population over 50 years. To date there is no established treatment 
for AION and therefore a better understanding of the events occurring at the level of the optic 
nerve head (ONH) would be important to design future therapeutic strategies. The optical 
properties of the eye allow the imaging of the optic nerve in vivo, which is a part of the CNS, 
during ischemia. Experimentally laser induced optic neuropathy (eLiON) displays similar 
anatomical features as anterior ischemic optic neuropathy in humans. After laser induced 
optic neuropathy we show that hyperreflective dots in optical coherence tomography 
correspond to mononuclear cells in histology. Using fluorescence-activated flow cytometry 
(FACS) we found these cells to peak one week after eLiON. These observations were 
translated to OCT findings in patients with AION, where similar dynamics of hyperreflective 
dots at the ONH were identified. Our data suggests that activated macrophages can be 
identified as hyperreflective dots in OCT. 
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1. INTRODUCTION 
Our sense of sight depends on an intact optic nerve (ON) which relays the visual 
information from the retina to the brain. The ON is part of the central nervous system (CNS) 
and is composed of myelinated retinal ganglion cell axons and supporting glial cells. Anterior 
ischemic optic neuropathy (AION) results from hypoperfusion or nonperfusion of the anterior 
part of the ON and is considered to be the equivalent of a white matter stroke (Hayreh, 2014; 
Bernstein et al., 2003). AION is the most common cause for sudden optic nerve related vision 
loss in patients over 50 and can be divided into a nonarteritic form (NA-AION) and an 
arteritic form (A-AION) (Hayreh, 1974) . NA-AION causes about 85% of sudden optic nerve-
related vision loss and typically affects individuals over 55 years of age. Although the exact 
pathophysiology of NA-AION is complex and not fully understood, numerous risk factors 
have been identified including vascular disorders such as systemic hypertension (Hayreh et 
al., 1994; Guyer et al., 1985; Salomon et al., 1999), diabetes mellitus (Lee et al., 2011) and 
smoking (Chung et al., 1994). A-AION is less common and usually affects persons over the 
age of 70 and is the most common ophthalmic manifestation of giant cell arteritis. The clinical 
course of both forms of AION is characterized by a sudden monocular loss of vision with 
edema of the optic disc resulting from axonal ischemia and localized infarction of the ON. 
Similar to CNS stroke where ischemia has been shown to elicit a profound inflammatory 
response mediated by proinflammatory cytokines and recruitment of leukocytes (Low et al., 
2014), inflammation has been reported to play a role in AION as well (Goldenberg-Cohen et 
al., 2004; Salgado et al., 2011). Because these observations are based on histology, there is 
scarce information on in vivo dynamics of leukocyte infiltrate after white matter ischemia. 
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Because of its unprecedented resolution, spectral-domain optical coherence tomography (SD-
OCT) has the potential to image leukocytes within the ON and the surrounding retinal tissue, 
with a resolution in the range of 5 µm to 7 µm, which exceeds the 10-25 µm measured for 
macrophages (Douglas and Tuluc, 2012).  
So called hyperreflective dots have recently been described in SD-OCT in diabetic 
macular edema and in intraocular inflammatory disorders (Vaz-Pereira et al., 2015; Saito et 
al., 2013) and have been attributed to inflammatory cells, although this has not been 
confirmed by histology so far. In this study we show that hyperreflective dots seen in SD-
OCT may correspond to macrophages in a mouse model of experimentally laser-induced optic 
neuropathy (eLiON) and that there is a characteristic time course of macrophage influx into 
the ON and the surrounding retina in the mouse which corresponds to the appearance of 
hyperreflective dots in the OCT of patients with AION.   
 
2. METHODS 
2.1 Animal experiments   
Male and female BALB/c wild-type (WT) mice were obtained from Charles River 
Laboratories (Sulzfeld, Germany). Male and female Cx3cr1+/gfp transgenic mice on a BALB/c 
background (more than 6 backcrosses to generate homozygous mice) were kindly provided by 
Prof. Steffen Jung (Weizmann Institute of Science, Rehovot, Israel) and homozygous mice 
were bred at the Central Animal Facility of the University of Bern (Murtenstrasse 31, Bern, 
Switzerland). CX3CR1gfp transgenic mice were generated by targeted replacement of the 
fractalkine receptor CX3CR1 gene with the cDNA encoding GFP (Jung et al., 2000). Thus, 
GFP is specifically expressed in microglia/macrophages of CX3CR1gfp mice.  
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Male/female BALB/c AnNCrl (6-8 weeks old, Charles River Laboratories, Sulzfeld, 
Germany) and CX3CR1gfp/gfp BALB/c mice (6 weeks old) were used in the present study. The 
animals were housed under pathogen free, temperature and humidity-controlled conditions in 
individually ventilated cages with an alternating 12-hour light/12-hour dark cycle. Food and 
water were provided ad libitum. For the eLiON induction and the SD-OCT studies the mice 
were anesthetized by intraperitoneal injection of ketamine (90 mg/kg, Ketalar, Orion Pharma 
AG, Zug, Zurich, Switzerland) and medetomidine hydrochloride (1.5 mg/kg, Domitor; Orion 
Pharma AG, Zug, Zurich, Switzerland). Atipamezol (Antisedan 5 mg/mL, Orion Pharma AG, 
Zug, Zurich, Switzerland) was used to antagonize medetomidine hydrochloride at the end of 
the intervention. At the end of the experiment, mice were euthanized with carbon dioxide 
(CO2) inhalation using 100% CO2 with a fill rate of about 30% of the chamber volume per 
minute.  
2.2 Generation of Bone Marrow Chimeras 
To identify the origin of microglia/macrophages in the retina we used CX3CR1gfp/gfp 
BALB/c mice which express GFP under the promoter of CX3CR1. Recipient mice received 
12-Gy γ-ray full body irradiation in two doses of 14 hours apart (6-Gy per dose). Donor mice 
were euthanatized, and femurs and tibia were harvested. Bone marrow was flushed out from 
bones with CSM buffer (2% FBS, 1% antibiotics, 0.01M HEPES in HBSS), and single cell 
suspensions were generated. The cells were filtered through a 70 µm mesh filter and 
centrifuged at 300 rpm for 5 min at 4°C. The pellet was re-suspended in 2% FBS in DMEM 
medium (Thermofisher scientific, Waltham, Massachusetts, USA) and trypan blue was used 
for the counting of the live cells. Recipient mice received 1 to 2 × 106 bone marrow cells 
intravenously in a maximum of 3 hours after the second dose of irradiation. Bone marrow 
chimera mice were left to recover for two weeks before any further intervention. During this 
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period mice received water supplied with antibiotics (0.8mg/ml sulfamethoxazol and 0.16 
mg/ml trimethoprim). 
2.3 Experimental laser-induced optic neuropathy (eLiON) 
 Experimental LiON was induced by a 532 nm laser photocoagulation (Visulas 532s, 
Carl Zeiss Meditec AG). A spot size of 500 µm with an energy level of 200 mW and 2.5s 
duration were used to directly target the optic nerve. Prior to the laser application rose bengal 
(40 mg/kg, Sigma-Aldrich) was injected intravenously to increase the laser uptake. Pupils 
were dilated with tropicamide 0,5%/phenylephrine 2,5% eye drops (Hospital Pharmacy, 
Inselspital, Bern, Switzerland).   
2.4 Tissue preparation and immunohistochemical studies 
 At selected time points, mice were euthanized and their eyes were removed and fixed 
in 4% parafolmaldehyde solution (PFA, pH 7.4) for 24 hours. Eyes were processed for routine 
paraffin embedding and slices of 5 µm were collected with a microtome (Leica, Biosystems, 
Muttenz, Switzerland) from the central retina containing the optic nerve head. Single staining 
with a rabbit polyclonal antibody against Iba-1 (1:5000, 016-20001, WAKO chemicals, 
Richmond, VA, USA) was performed  in control and eAION BALB/c mice using a 
biotinylated anti-rabbit IgG (H&L) antibody (Vector Laboratories, BA-100, Burlingame, CA, 
USA) followed by incubation in a streptavidin Alexa Fluor 488 conjugate antibody (Thermo 
Fisher Scientific, S32354, Waltham, MA, USA). To investigate the infiltration of microglia 
cells into the retina during the course of AION, co-localization studies were performed in 
chimera mice using a chicken polyclonal antibody against GFP (1:100, ab13970, Abcam, 
Cambridge, UK) and a rabbit polyclonal antibody against Iba-1 (1:5000, 016-20001, WAKO 
chemicals, Richmond, VA, USA). Briefly, the sections were routinely de-paraffinized and 
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peroxidase activity was blocked by incubation in 0.5% H2O2 in methanol. The retrieval of the 
antigen epitopes was achieved by incubation in citrate buffer (10 mM, pH 6.0, 95 °C, 10 min). 
The secondary antibodies pre-absorbed goat polyclonal to chicken IgY H&L (FITCH) 
(1:1000, ab7114, Abcam, Cambridge, UK ) and goat anti-rabbit IgG (H+L), Alexa Fluor 594 
conjugate (1:1000, A27016, Thermofisher scientific, Waltham, Massachusetts, USA) were 
used for the detection of GFP and Iba-1, respectively. Slides were mounted in mounting 
medium with DAPI (Vector Laboratories, Burlingame, CA, USA), cover slipped and 
observed in the microscope.     
2.5 Histological staining 
For the evaluation of morphological changes, retinal sections from experimental mice 
were histologically examined, using a standard hematoxylin-eosin staining protocol 7 days 
after the eLION induction. Briefly, the sections were routinely de-paraffinized in xylol, 
rehydrated and consecutively stained with hematoxylin and eosin. Dehydration of the sections 
was achieved with ethanol. Finally, the sections were mounted with Eukitt (O. Kindler GmbH 
& Co, Freiburg, Germany).   
2.6 Microscopy 
Light and optical microscopy images were taken with an epifluorescence microscope 
(Olympus BX60 microscope; Olympus, Tokyo, Japan). Adjustments of light and contrast 
were achieved with the use of the commercial software Photoshop ver. 7.0 (Adobe Systems, 
San Jose, CA) and the figures were finalized in CorelDraw (Corel Corporation of Ottawa, 
Canada).  
2.7 Fluorescence-Activated Flow Cytometry - FACS analysis 
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Retinas were processed for FACS analysis 3, 7 and 14 days after eLiON induction. 
Briefly, the retinas were isolated and dissociated in 0.4 Wünsch Liberase TM Grade (Roche, 
Basel, Switzerland) in DPBS/0.01% DNAse I (Roche, Basel, Switzerland) at 37 ºC for 30 
min. Single cell suspensions were obtained and re-suspended in 500µl DPBS/0.01% DNAse. 
1µl of DAPI (Thermo Fisher Scientific, Waltham, MA, USA) was added in each sample and 
the samples were incubated for 30sec at RT for the staining of dead cells. The samples were 
washed in DPBS/0.01% DNAse and re-suspended in 200µl of FACS buffer (100mM EDTA, 
20% FBS, 0.5% Na-Azide, in DPBS/DNAse 0.01%) for antibody staining. Macrophages were 
identified using fluorescent-labelled antibodies against CD45 (30-F11, #103116, 1:100), 
F4/80 (BM8, #123110, 1:60), CD11b (M1/70, #101212, 1:100), MHC-II (major 
histocompatibility complex class-II, AF6-120.1, #116422, 1:100) and CD68 (FA-11, 
#137010, 1:100). Samples were incubated for 20min in the antibody pool, washed again and 
re-suspended in 800µl of FACS buffer. Samples were analyzed in a LSR II Cytometer System 
and the BD FACSDIVA™ software (BD Biosciences, Allschwil, Switzerland). Flowjo Single 
Cell Analysis Software V10 was used for the analysis of the FACS data (TreeStar, Ashland, 
OR). All antibodies were purchased from Biolegend (San Diego, California, USA). 
2.8 Patient selection  
This study was based on retrospective analysis of data from patients of the outpatient 
clinic of the Department of Ophthalmology at the University Hospital Bern, Switzerland back 
to the year 2007. Patients were selected from the database of back-up reports. Patients with a 
history of age-related macular degeneration (AMD), choroid neovascularisation (CNV), 
glaucoma and all cases before the year 2007 (no OCT have been made before 2007) were 
excluded. Of the remaining 129 patients, 68 had been examined by OCT at least once. In 33 
cases, OCT had been performed in the acute phase of AION with follow up OCTs.  Of these 
33 patients 10 had A-AION and 23 had NA-AION.  
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2.9 Spectral Domain Optical Coherence Tomography – SD-OCT 
Mice: OCT images of mice were taken with a SD- OCT (Heidelberg Engineering GmbH, 
Heidelberg, Germany) that was adapted for mouse imaging. A 78D ophthalmic slit lamp lens 
(Volk Optical Inc., Ohio, USA) was adjusted on the standard 30° Heidelberg Spectralis lens 
and a contact lens (Quantum I, Bausch + Lomb Inc., Rochester, NY) was placed on the mouse 
eye. OCT images of patients were acquired with a SD- OCT (Heidelberg Engineering GmbH, 
Heidelberg, Germany) with a scan around the optic nerve head.  
Ambient light was reduced to nearly zero lux for noise reduction. The images were taken in 
‘grid mode’ and ‘cylindrical mode’ at high resolution (1008 x 596 pixels). Infrared images 
were obtained at a resolution of 1’536 x 1’536 pixels. 
2.10 Quantification studies 
Hyperreflective dots were counted manually on cylindrical OCTs of human patients 
obtained with the Heidelberg software. Cylindrical OCTs were acquired in a diameter of 3.4 ± 
0.04 mm (mean ± S.E.M.) around the optic nerve head.  Quantification of the OCT data was 
performed at different time points after initial symptoms. Time after initial symptoms was 
defined as the time after onset of the patient’s initial symptoms. 
Mouse retinal thickness was quantified using the Heidelberg software after manual 
correction of the base membrane and inner limiting membrane. Vertical scans from the centre 
of the optic nerve were used for the quantification.   
 
2.11 Statistics  
For the statistical analysis the GraphPad Prism 5.0 software was used (GraphPad 
Software, Inc, San Diego, CA, USA). Statistically significant differences of the OCT 
quantification data were determined using ordinary one way ANOVA followed by Tukey`s 
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post-hoc tests. One way ANOVA followed by Tukey post hoc analysis tests was used for the 
determination of statistically significant differences of the FACS data. Two way ANOVA was 
used for the statistical analysis of retinal thickness measurements. P values less than 0.05 
were considered statistically significant. All data are expressed as mean ± S.E.M. 
2.12 Study approval  
All animal procedures were conducted in accordance with the ARVO Statement for 
the Use of Animals in Ophthalmic and Vision Research and was approved by the local 
Animal Ethics Committee (Veterinärdienst des Kantons Bern: BE 38/13). 
The human study followed the tenets of the Declaration of Helsinki, and Ethics 
Committee approval had been obtained (KEK-Nr. 370/14).  
 
3. RESULTS 
3.1 Macrophage accumulation in the optic nerve and surrounding retina after eLiON  
Optical coherence tomography of the optic nerve head in naïve animals showed a 
well-defined optic nerve head with intact layers of the surrounding retinal layers. Furthermore 
hyperreflective dots were absent in the optic nerve head and the vitreous (Figure 1A,C). Three 
days after induction of eLiON, there was marked swelling of the optic nerve head with 
hyperreflective dots appearing within the optic nerve head and the vitreous (Figure 1B) and 
mononuclear cells within the optic nerve head and the vitreous in H&E stains (Figure 1D). 
To localize and to identify blood-borne macrophages in the optic nerve head, we used 
bone marrow chimera mice that were lethally irradiated and transplanted with GFP-expressing 
bone marrow cells. Co-localization within the ischemic area revealed that these GFP+ cells 
expressed Iba-1 and confirmed that they derived from the circulating bone marrow derived 
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myeloid population and not activated microglia from the host’s resident ON population. Iba-1 
is a microglia/macrophage-specific calcium binding protein that is expressed by macrophages 
and central nervous system microglial cells (Ahmed et al., 2007). In control mice, GFP 
expression was absent on Iba-1 positive cells (Figure 1F) and these cells were less abundant 
compared to eLiON mice (Figure 1J). Moreover, microglial Iba-1+ cells had a ramified 
phenotype characterized by a small soma and thin cell processes, typical for resting microglia 
(Figure 1G) (Wilms et al., 1997). In contrast, GFP+Iba1+ cells in eLiON mice displayed a 
more phagocytic-like phenotype with round cytosol and retracted processes (Figure 1 H&I), 
corresponding to activated macrophages. Analysis of conventional hematoxylin and eosin 
histology confirmed swelling of the optic nerve head (asterisk in Figure 1D) with dilatation of 
optic nerve head vessels (Figure 1D).   Optic nerve injury was also present in eLiON eyes 
accompanied by formation of retinal folds in the peripapillary area (Figure 1D). 
 
3.2 Quantification and time course of macrophage accumulation in the ON and the 
surrounding retina in eLiON 
Quantification of retinal thickness in mouse retinas revealed statistically significant 
swelling of the ON and the surrounding retina in the eLiON mice 3 days after the laser 
application (Figure 2A).  For quantification of macrophage populations in eLiON, 
fluorescence-activated flow cytometry (FACS) was performed in eLiON and controls at 
different time points after the laser application. The number of CD45+CD11b+F4/80+ cells, 
representing macrophages, increased significantly 7 days after eLiON (Figure 2C, top graph, 
***p<0.001 compared to control). Thereafter macrophage numbers decreased but were still 
elevated compared to controls (Figure 2C, top graph, **p<0.01 compared to control). In order 
to assess whether these macrophages were activated, we assessed up regulation of major 
histocompatibility complex class 2 (MHC-II) and CD68. The numbers of CD68+MHC-II+ 
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cells were significantly elevated 7 days after the laser application confirming that these 
macrophages were activated, while these  numbers rapidly decreased and reached similar 
levels as the controls at day 14 (Figure 2C, bottom graph, ***p<0.001 compared to control).    
3.3 Correlation between SD-OCT findings in eLiON and AION in humans   
Thirty three patients with AION were included and demographic data is summarized 
in table 1. Ten patients had A-AION and 23 patients had NA-AION. The indication for OCT 
imaging was made in the clinical routine to analyze peripapillary nerve fibre thickness (Figure 
2E). This resulted in a heterogenous sampling rate and follow up time. The A-AION patient 
group included 4 males and 6 females with a mean age of 77± 6.9 years. Giant cell arteritis 
was verified in all 10 patients by a positive biopsy-result of the temporal artery. The NA-
AION patient group included 13 males and 10 females with a mean age of 67± 13.0 years. 
Figure 2E shows representative images obtained from cross section (upper panels) and 
cylindrical OCTs (bottom panels) in humans one week after initial symptoms. Both in mice 
(Figure 2B) and humans a marked swelling of the nerve fibre layer of the optic nerve head can 
be seen. Furthermore, hyperreflective dots can be observed in both eLiON and AION eyes, 
especially in the optic nerve head and the surrounding retina and within the vitreous. 
3.4 Quantification and time course of inflammatory cells in SD-OCT in patients with 
AION 
Peripapillary SD-OCT scans were performed in human patients at various time points 
after initial symptoms of AION. Hyperreflective dots in the retina as well as in the vitreous 
were observed, similar to the hyperreflective dots observed in eLiON mice. Manual counts of 
the number of hyperreflective dots in the retina (peripapillary area) peaked 2 weeks after 
initial reported symptoms and declined thereafter (Figure 2F bottom, p<0.01, ordinary one 
was ANOVA). Tukey`s post-hoc analysis revealed statistical significant reduction of 
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hyperreflective dot counts between 2 weeks and 15-70 weeks after initial symptoms 
**p<0.01). On the other hand, hyperreflective dots were less abundant in the vitreous (Figure 
2F, top). No significant differences were observed in the number of hyperreflective dots 
between A-AION and NA-AION patients neither in the retina nor in the vitreous (data not 
shown), however as all A-AION patient received high dose corticosteroid treatment, this data 
needs to be interpreted with caution. Quantification of hyperreflective dots in different retinal 
layers revealed elevated numbers in the outer plexiform layer (OPL) (p<0.01, ordinary One 
way ANOVA) and the outer nuclear layer (p<0.05, ordinary One way ANOVA) (ONL) which 
peaked at 2 weeka after initial symptoms and decreased over time (Figure 3A-E). Statistically 
significant differences were observed between different time points in the INL (Figure 3E; 
week 2 vs week 15-70, *p<0.05; ordinary One way ANOVA followed by Tukey`s post-hoc 
analysis) and the OPL (Figure 3E; week 2 vs week 15-70, *p<0.05; ordinary One way 
ANOVA followed by Tukey`s post-hoc analysis).  No statistically significant difference was 
observed in the inner retinal layers such as the nerve fibre layer and the ganglion cell layer 
(Figure 3E).  
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4. DISCUSSION 
It is well accepted that acute ischemia of the anterior part of the optic nerve head is the 
cause of AION which is followed by retinal ganglion cell axon degeneration and apoptotic 
cell death of the ganglion cells (Levin and Louhab, 1996). It has been recently suggested that 
similar to inflammation following CNS stroke, inflammatory processes may play a role in the 
course of AION as well (Zhang et al., 2009; Goldenberg-Cohen et al., 2004; Salgado et al., 
2011). However, the majority of these observations are based on histological findings, and 
few in vivo data is available regarding the dynamics of leukocyte infiltration after white 
matter ischemia in general. 
In the present study a murine model of laser-induced optic neuropathy (eLiON), 
characterized by optic nerve injury and optic nerve swelling, in combination with in vivo 
imaging using optical coherence tomography was used for the investigation of the dynamics 
of microglia/macrophages during the disease. The co-localization of microglia marker Iba-1 
with GFP - expressed on circulating myeloid derived cells of CX3CR1gfp/gfp mice - showed 
that blood derived circulating macrophages migrate into the optic nerve and surrounding 
retina during the early stages of eLiON. However, despite the fact that all GFP positive cells 
were co-localized with Iba-1, this was not a “vice versa phenomenon”, suggesting that the 
activated macrophages population during the course of eLiON correspond both to the 
activation of resident microglia and to the recruitment of circulating macrophages. Indeed, 
activation of microglia has been reported using histology in rodent models of optic nerve 
injury (Garcia-Valenzuela and Sharma, 1999; Zhang and Tso, 2003; Thanos, 1992) and 
infiltration of macrophages has been observed in the optic nerve of rats and primates 
subjected to eAION (Slater et al., 2013; Salgado et al., 2011). Resident microglia - present in 
the retina and the brain in a resting stage- are activated under infectious and inflammatory 
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conditions and contribute to the maintenance of tissue homeostasis by removing cellular 
debris (Langmann, 2007).  
SD-OCT was used as a non-invasive technique for the investigation of retinal 
alterations in eLiON mice. OCT scans revealed the appearance of hyperreflective dots in the 
retina and vitreous of eLiON-subjected mice 3 days after the induction of the disease. 
Interestingly, a similar morphology and time course of hyperreflective dots was identifiable in 
humans diagnosed with AION during the acute phase of the disease, namely 1-2 weeks after 
the initial symptoms of visual deficits. This difference may be explained by the fact that 
patients with AION often only were rescheduled for a follow up more than one week after 
initial onset of symptoms. 
 Hyperreflective dots, elsewhere referred as small dense particles (Framme et al., 
2010) or hyperreflective foci (Framme et al., 2012), have been observed in several retinal 
diseases including age-related macular degeneration (AMD) (Framme et al., 2010) diabetic 
macular edema (DME) (Bolz et al., 2009; Ota et al., 2010; Horii et al., 2012) and retinal vein 
occlusion (RVO) (Coscas et al., 2011; Ogino et al., 2012) but their origin remains still 
controversial. According to one hypothesis hyperreflective dots may represent inflammatory 
cells or activated macrophages that phagocytose degenerated retinal neurons (Vujosevic et al., 
2013; Framme et al., 2010; Nowak, 2006). Indeed, the presence of activated macrophages has 
been observed in various conditions of retinal disease (Sekiryu et al., 2012; Omri et al., 2011; 
Cruz-Guilloty et al., 2013).  
However, the beneficial or deleterious role of macrophages in the course of AION, 
and in white matter stroke in general, is still controversial. Macrophages are a heterogeneous 
population of cells that can lead either to inflammation or act in an anti-inflammatory manner 
promoting angiogenesis. This heterogeneity brings limitations on the investigation of the role 
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of these cells in the pathophysiology of retinal disease. It has been previously suggested that 
macrophage invasion into the retina precedes degeneration and retinal cell death under 
pathological conditions (Caicedo et al., 2005). Thus, one could speculate that activation of 
resident microglia or recruitment of circulating macrophages is involved in triggering or 
facilitating retinal degeneration. Activated macrophages are believed to have a greater 
destructive potential compared to resident microglia (Gordon, 1995), therefore, invading 
macrophages may cause alterations in retinal function. Additional studies are necessary for 
the investigation of the role of these cells in the pathophysiology of AION. Such studies could 
provide useful information and may help to establish therapeutic targets for the treatment of 
AION.  
5. CONCLUSIONS 
The animal experiments of the present study suggested that the hyperreflective dots that 
are detected in the OCT scans correspond to activated macrophages invading the retina in the 
early phase of laser-induced model of optic neuropathy and may contribute to changes in the 
retinal physiology. The involvement of inflammatory components such as 
microglia/macrophages in CNS ischemia following stroke has been previously characterized 
(Kochanek and Hallenbeck, 1992).  Thus, if hyperreflective dots correspond to activated 
macrophages, then SD-OCT could be used as a new method to monitor inflammatory 
components during anterior ischemic optic neuropathy.  
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Figure Legends 
Figure 1: Retinal morphology and retinal microglia in experimental laser-induced optic 
neuropathy (eLiON). A, B. Representative retinal OCT scans of the optic nerve before (A, 
n=10) and 3 days after eLiON (B, n=10). The scan location is indicated in the infrared fundus 
photographs (left). Hyperreflective dots (representative cell enlarged in yellow box) are 
observed 3 days after eLiON in the vitreous next to the swollen optic disc. C-E. 
Representative images of hematoxylin-eosin staining in control bone marrow chimera mice 
(C, n=4) and eLiON-subjected bone marrow chimera mice (D, n=6). In eLiON (D) cells are 
found in the vitreous and close to the optic nerve head (E) 7 days after the laser application. 
Retinal folds are present in the peripapillary area (arrows). Asterisk is optic nerve head. F-J. 
Co-localization studies in bone marrow chimera mice reveal infiltration of grafted GFP-
positive cells into the retina of eLiON mice (I, n=6). All GFP-positive cells express the 
microglial marker Iba-1 in eLiON and have amoeboid morphology (H, Iba-1; I, GFP; J, 
merged). GFP-positive cells are absent in control retina (F, n=4), where Iba-1-positive cells 
are less abundant and have a ramified morphology (G). Scale bars in OCT scans in A: 200 
µm; in C, D, F, H, I, J: 200 µm; in E, G: 20 µm. Magnification in C, D, F, H, I, J: 10x; in E: 
100x; in G: 40x.  
Figure 2: Comparison of experimental laser-induced optic neuropathy (eLiON) in mice 
and anterior ischemic optic neuropathy (AION) in humans. A. Mouse retinal thickness 
around the optic nerve head before and after eLiON (n=9, ***p<0.001 compared to Baseline, 
two way ANOVA). B. Representative transverse optical coherence tomography scan of the 
optic nerve head (top scans, location shown on respective near-infrared fundus image) and 
retinal nerve fibre layer thickness scan (bottom scans) in mice 3 days post eLiON. C. 
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Macrophage dynamics with representative FACS plots (left panel) and bar graphs of 
macrophage accumulation in the retina at indicated days after eLiON (n≥6, **p<0.01, 
***p<0.001 compared to CTRL, one way ANOVA, data from one of at least 2 independent 
experiments are shown) demonstrating macrophage cell population (top right quarter, 
CD45+F4/80+CD11b+) in control (CTRL) and eLiON retinas at days 3, 7 and 14 after the laser 
application. D. Study design and patient selection E. Representative transverse optical 
coherence tomography scan of the optic nerve head (top scans,  location shown on respective 
near-infrared fundus image) and retinal nerve fibre layer thickness scan (bottom scans) of a 
human patient 1 week after initial symptoms. Hyperreflective dots are apparent in the human 
retina and adjacent vitreous (yellow squares). F. Quantification of hyperreflective dots in 
vitreous (top) and retina (bottom) (vitreous: 1 week, n=11; 2 weeks, n=13; 3-4 weeks, n=7; 5-
7 weeks, n=5; 8-14 weeks, n=5; 15-70 weeks, n=12; retina: 1 week, n=11; 2 weeks, n=11; 3-4 
weeks, n=6; 5-7 weeks, n=5; 8-14 weeks, n=5; 15-70 weeks, n=10). A significant increase of 
hyperreflective dots was observed in the retina (p<0.01, ordinary one way ANOVA). Highest 
levels were detected two weeks after initial symptoms and were statistically different from the 
counts 15-70 days weeks after initial symptoms (**p<0.01).  
Figure 3: Kinetics of peripapillary hyperreflective dots in different retinal layers in 
humans with anterior ischemic optic neuropathy. Serial optical coherence tomography 
scans of a representative patient at 1, 2, 3-4 and 15-70 weeks after onset of symptoms (left 
panel, A, B, C and D, respectively). E. Serial counts in different retinal layers. A significant 
change of hyperreflective dots density over time was detected only in the outer plexiform 
(p<0.01, ordinary one way ANOVA) and the outer nuclear retinal layer (p<0.05, ordinary one 
way ANOVA) (1 week, n=10; 2 weeks, n=11; 3-4 weeks, n=5; 5-7 weeks, n=6; 8-14 weeks, 
n=4; 15-70 weeks, n=4). No statistical significant changes were observed in the ganglion cell 
layer, inner plexiform or inner nuclear layer (p>0.05, ordinary one way ANOVA). 
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Statistically significant differences were observed between different time points in the INL 
and the OPL (INL: week 2 vs week 15-70, *p<0.05; OPL: week 2 vs week 15-70, *p<0.05; 
ordinary One way ANOVA followed by Tukey`s post-hoc analysis). GCL, ganglion cell 
layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, 
outer nuclear layer.  
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Table 1: Demographic data 
 
 A-AION NA-AION total 
n 10 23 33 
age 77 ± 6.9 67 ± 13 72 ± 12 
Gender (male:female) 4:6 13:10 17:16 
Diabetes 1 4 5 
Arterial hypertension 2 7 9 
Biopsy 10 3 13 
Eye (OD:OS) 4:6 16:9 20:15 
Visual acuity at presentation 
(LogMAR) 
2.16 1.04 2.65 
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Highlights 
• Macrophages are recruited via the optic nerve into the surrounding retina after 
experimental anterior ischemic optic neuropathy 
• Hyperreflective dots in spectral domain optical coherence tomography correspond to 
activated macrophages  
• Macrophage accumulation can be imaged and quantified in vivo with SD-OCT  
• Spectral domain optical coherence tomography could be used to assess the 
inflammatory components during optic nerve ischemia  
